Expression of calcium channel subunit variants in small mesenteric arteries of WKY and SHR

American Journal of Hypertension

Volumn 28, Issue 10, 2015, Pages 1229-1239

  Cox, Robert H ^a   Fromme, Samantha ^a  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

alternative splicing; blood pressure; Ca2+ channel subunits; gene expression; hypertension; hypertensive rats; protein abundance; small mesenteric arteries; voltage gated Ca2+ channels

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL SUBUNIT VARIANT; MESSENGER RNA; NIFEDIPINE; UNCLASSIFIED DRUG; ISOPROTEIN; PROTEIN SUBUNIT;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CELL ISOLATION; CONSENSUS SEQUENCE; CURRENT DENSITY; EXON; GENE EXPRESSION; HEART WEIGHT; IMMUNOBLOTTING; MALE; MESENTERIC ARTERY; MOLECULAR CLONING; MUSCLE CELL; NONHUMAN; OPEN READING FRAME; PATCH CLAMP TECHNIQUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION SITE; RNA ISOLATION; SYSTOLIC BLOOD PRESSURE; VOLTAGE CLAMP TECHNIQUE; ANIMAL; GENE EXPRESSION PROFILING; HYPERTENSION; METABOLISM; PROTEIN SUBUNIT; SMOOTH MUSCLE CELL; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANIMALS; CALCIUM CHANNELS; GENE EXPRESSION PROFILING; HYPERTENSION; MALE; MESENTERIC ARTERIES; MYOCYTES, SMOOTH MUSCLE; PROTEIN ISOFORMS; PROTEIN SUBUNITS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 84943607025     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpv024     Document Type: Article

References (33)

1. Sonoyama K, Greenstein A, Price A, Khavandi K, Heagerty T. Vascular remodeling: implications for small artery function and target organ damage. Ther Adv Cardiovasc Dis 2007; 1:129-137.
2. Drazner MH. The progression of hypertensive heart disease. Circulation 2011; 123:327-334.
3. Cox RH, Rusch NJ. New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure. Microcirculation 2002; 9:243-257.
4. Matsuda K, Lozinskaya I, Cox RH. Augmented contributions of voltagegated Ca2+ channels to contractile responses in spontaneously hypertensive rat mesenteric arteries. Am J Hypertens 1997; 10:1231-1239.
5. Stekiel WJ. Electrophysiological mechanisms of force development by vascular smooth muscle in hypertension. In RMKW Lee (ed), Blood Vessel Changes in Hypertension: Structure and Function, Vol 2. CRC Press, Inc.: Boca Raton, FL, 1989, pp. 127-170.
6. Lozinskaya IM, Cox RH. Effects of age on Ca2+ currents in small mesenteric artery myocytes from Wistar-Kyoto and spontaneously hypertensive rats. Hypertension 1997; 29:1329-1336.
7. Cox RH, Lozinskaya IM. Ca2+ channel inactivation in small mesenteric arteries of WKY and SHR. Am J Hypertens 2008; 21:406-412.
8. Varadi G, Mori Y, Mikala G, Schwartz A. Molecular determinants of Ca2+ channel function and drug action. Trends Pharmacol Sci 1995; 16:43-49.
9. Cox RH, Fromme SJ, Folander KL, Swanson RJ. Voltage gated K+ channel expression in arteries of Wistar-Kyoto and spontaneously hypertensive rats. Am J Hypertens 2008; 21:213-218.
10. Cox RH, Folander K, Swanson R. Differential expression of voltagegated K(+) channel genes in arteries from spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 2001; 37:1315-1322.
11. Tang ZZ, Hong X, Wang J, Soong TW. Signature combinatorial splicing profiles of rat cardiac-And smooth-muscle Cav1.2 channels with distinct biophysical properties. Cell Calcium 2007; 41:417-428.
12. Cheng X, Liu J, Asuncion-Chin M, Blaskova E, Bannister JP, Dopico AM, Jaggar JH. A novel Ca(V)1.2 N terminus expressed in smooth muscle cells of resistance size arteries modifies channel regulation by auxiliary subunits. J Biol Chem 2007; 282:29211-29221.
13. Soldatov NM, Bouron A, Reuter H. Different voltage-dependent inhibition by dihydropyridines of human Ca2+ channel splice variants. J Biol Chem 1995; 270:10540-10543.
14. Birnbaumer L, Qin N, Olcese R, Tareilus E, Platano D, Costantin J, Stefani E. Structures and functions of calcium channel beta subunits. J Bioenerg Biomembr 1998; 30:357-375.
15. Klugbauer N, Marais E, Hofmann F. Calcium channel alpha2delta subunits: differential expression, function, and drug binding. J Bioenerg Biomembr 2003; 35:639-647.
16. Gerhardstein BL, Gao T, Bunemann M, Puri TS, Adair A, Ma H, Hosey MM. Proteolytic processing of the C terminus of the alpha(1C) subunit of L-Type calcium channels and the role of a proline-rich domain in membrane tethering of proteolytic fragments. J Biol Chem 2000; 275:8556-8563.
17. Cox RH, Fromme SJ. A naturally occurring truncated Cav1.2 α1-subunit inhibits Ca2+ current in A7r5 cells. Am J Physiol Cell Physiol 2013; 305:C896-C905.
18. Liao P, Yu D, Lu S, Tang Z, Liang MC, Zeng S, Lin W, Soong TW. Smooth muscle-selective alternatively spliced exon generates functional variation in Cav1.2 calcium channels. J Biol Chem 2004; 279:50329-50335.
19. Cens T, Restituito S, Galas S, Charnet P. Voltage and calcium use the same molecular determinants to inactivate calcium channels. J Biol Chem 1999; 274:5483-5490.
20. Bannister JP, Bulley S, Narayanan D, Thomas-Gatewood C, Luzny P, Pachuau J, Jaggar JH. Transcriptional upregulation of α2δ-1 elevates arterial smooth muscle cell voltage-dependent Ca2+ channel surface expression and cerebrovascular constriction in genetic hypertension. Hypertension 2012; 60:1006-1015.
21. Kharade SV, Sonkusare SK, Srivastava AK, Thakali KM, Fletcher TW, Rhee SW, Rusch NJ. The β3 subunit contributes to vascular calcium channel upregulation and hypertension in angiotensin II-infused C57BL/6 mice. Hypertension 2013; 61:137-142.
22. Pratt PF, Bonnet S, Ludwig LM, Bonnet P, Rusch NJ. Upregulation of L-Type Ca2+ channels in mesenteric and skeletal arteries of SHR. Hypertension 2002; 40:214-219.
23. Wang WZ, Saada N, Dai B, Pang L, Palade P. Vascular-specific increase in exon 1B-encoded CAV1.2 channels in spontaneously hypertensive rats. Am J Hypertens 2006; 19:823-831.
24. Soldatov NM. Genomic structure of human L-Type Ca2+ channel. Genomics 1994; 22:77-87.
25. Moore MJ, Silver PA. Global analysis of mRNA splicing. RNA 2008; 14:197-203.
26. Li Q, Sarna SK. Chronic stress targets posttranscriptional mechanisms to rapidly upregulate α1C-subunit of Cav1.2b calcium channels in colonic smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2011; 300:G154-G163.
27. Brust PF, Simerson S, McCue AF, Deal CR, Schoonmaker S, Williams ME, Velicelebi G, Johnson EC, Harpold MM, Ellis SB. Human neuronal voltage-dependent calcium channels: studies on subunit structure and role in channel assembly. Neuropharmacology 1993; 32:1089-1102.
28. Murakami M, Yamamura H, Suzuki T, Kang MG, Ohya S, Murakami A, Miyoshi I, Sasano H, Muraki K, Hano T, Kasai N, Nakayama S, Campbell KP, Flockerzi V, Imaizumi Y, Yanagisawa T, Iijima T. Modified cardiovascular L-Type channels in mice lacking the voltage-dependent Ca2+ channel beta3 subunit. J Biol Chem 2003; 278:43261-43267.
29. Tang ZZ, Zheng S, Nikolic J, Black DL. Developmental control of CaV1.2 L-Type calcium channel splicing by Fox proteins. Mol Cell Biol 2009; 29:4757-4765.
30. Cox RH, Lozinskaya I, Matsuda K, Dietz NJ. Ramipril treatment alters Ca(2+) and K(+) channels in small mesenteric arteries from Wistar-Kyoto and spontaneously hypertensive rats. Am J Hypertens 2002; 15:879-890.
31. Pesic A, Madden JA, Pesic M, Rusch NJ. High blood pressure upregulates arterial L-Type Ca2+ channels: is membrane depolarization the signal?. Circ Res 2004; 94:e97-e104.
32. Chen M, Manley JL. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009; 10:741-754.
33. Chiu YH, Alvarez-Baron C, Kim EY, Dryer SE. Dominant-negative regulation of cell surface expression by a pentapeptide motif at the extreme COOH terminus of an Slo1 calcium-Activated potassium channel splice variant. Mol Pharmacol 2010; 77:497-507.